Beauveriolides, including the main beauveriolide I {systematic name: (3R,6S,9S,13S)-9-benzyl-13-[(2S)-hexan-2-yl]-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotridecane-2,5,8,11-tetrone, C27H41N3O5}, are a series of cyclodepsipeptides that have shown promising results in the treatment of Alzheimer's disease and in the prevention of foam cell formation in atherosclerosis. Their crystal structure studies have been difficult due to their tiny crystal size and fibre-like morphology, until now. Recent developments in 3D electron diffraction methodology have made it possible to accurately study the crystal structures of submicron crystals by overcoming the problems of beam sensitivity and dynamical scattering. In this study, the absolute structure of beauveriolide I was determined by 3D electron diffraction. The cyclodepsipeptide crystallizes in the space group I2 with lattice parameters a = 40.2744 (4), b = 5.0976 (5), c = 27.698 (4) Å and β = 105.729 (6)°. After dynamical refinement, its absolute structure was determined by comparing the R factors and calculating the z-scores of the two possible enantiomorphs of beauveriolide I.

Biology Centre Czech Academy of Sciences Branišovská 1160 31 České Budějovice 2 370 05 Czech Republic

Department of Structure Analysis Institute of Physics of the Czech Academy of Sciences Na Slovance 1999 2 Prague 8 18221 Czech Republic

Zobrazit více v PubMed

Brázda, P., Palatinus, L. & Babor, M. (2019). Science, 364, 667–669. PubMed

Elsworth, J. F. & Grove, J. F. (1977). J. Chem. Soc. Perkin Trans. 1, pp. 270–273. PubMed

Gemmi, M., Mugnaioli, E., Gorelik, T. E., Kolb, U., Palatinus, L., Boullay, P., Hovmöller, S. & Abrahams, J. P. (2019). ACS Cent. Sci. 5, 1315–1329. PubMed PMC

Hardy, J. & Selkoe, D. J. (2002). Science, 297, 353–356. PubMed

Heneberg, P., Jegorov, A. & Šimek, P. (2020). CyTA J. Food, 18, 644–652.

Huttunen, H. J., Greco, C. & Kovacs, D. M. (2007). FEBS Lett. 581, 1688–1692. PubMed PMC

Kadlec, Z., Šimek, P., Heydová, A., Jegorov, A., Maťha, V., Landa, Z. & Eyal, J. (1994). Biochem. Syst. Ecol. 22, 803–806.

Klar, P. B., Krysiak, Y., Xu, H., Steciuk, G., Cho, J., Zou, X. & Palatinus, L. (2023). Nat. Chem. 15, 848–855. PubMed PMC

Mochizuki, K., Ohmori, K., Tamura, H., Shizuri, Y., Nishiyama, S., Miyoshi, E. & Yamamura, S. (1993). Bull. Chem. Soc. Jpn, 66, 3041–3046.

Momma, K. & Izumi, F. (2008). J. Appl. Cryst. 41, 653–658.

Nagai, K., Doi, T., Ohshiro, T., Sunazuka, T., Tomoda, H., Takahashi, T. & Ōmura, S. (2008). Bioorg. Med. Chem. Lett. 18, 4397–4400. PubMed

Namatame, I., Tomoda, H., Ishibashi, S. & Ōmura, S. (2004). Proc. Natl Acad. Sci. USA, 101, 737–742. PubMed PMC

Palatinus, L., Brázda, P., Jelínek, M., Hrdá, J., Steciuk, G. & Klementová, M. (2019). Acta Cryst. B75, 512–522. PubMed

Palatinus, L., Petříček, V. & Corrêa, C. A. (2015). Acta Cryst. A71, 235–244. PubMed

Petříček, V., Palatinus, L., Plášil, J. & Dušek, M. (2023). Z. Kristallogr. Cryst. Mater. 238, 271–282.

Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A., Berezovska, O., Hyman, B. T., Chang, T. Y., Tanzi, R. E. & Kovacs, D. M. (2001). Nat. Cell Biol. 3, 905–912. PubMed

Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.

Spence, J. C. H., Zuo, J. M., O’Keeffe, M., Marthinsen, K. & Hoier, R. (1994). Acta Cryst. A50, 647–650.

Tomoda, H. & Doi, T. (2008). Acc. Chem. Res. 41, 32–39. PubMed